PepTalk 2017
PepTalk 2017

Pipeline One Header

Cambridge Healthtech Institute’s Second Annual
Emerging Technologies for Antibody Discovery

Cutting-Edge Technologies to Enable the Discovery of Novel 
Biotherapeutic Targets for Antibodies and Emerging Constructs


January 12-13, 2017 | Hilton San Diego Bayfront | San Diego, CA

As large pharma continues its integration of biologic drugs into its product portfolios and discovery operations, it is imperative that industry companies identify truly novel drug targets for unmet medical needs. The Emerging Technologies for Antibody Discovery meeting offers a forum for showcasing the current state of the art for research methodologies that will support the discovery of next-generation biotherapeutics. The meeting explores the evolution of traditional library and display approaches, along with emerging technologies with the potential to have significant near-term impacts on the ability of scientists to discover and develop unique, differentiated biologic drugs.

We invite presentation proposals on the following preliminary topics:

  • Antigen-specific cell sorting
  • Computational and structural approaches to target discovery and biotherapeutic design
  • Deep sequencing of antibody selections
  • Imaging technologies in antibody discovery
  • In vivo antibody selection methodologies
  • Microfluidic and biosensor technologies for antibody discovery
  • Next-generation antibody discovery libraries
  • Single-cell antibody cloning and sequencing
  • Structural biology in antibody discovery
  • Understanding the signaling pathways of emerging targets

Please click here to submit a speaking proposal for review.

Deadline for submission: May 27, 2016

All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference program. Please note that due to limited speaking slots, preference will be given to abstracts from those within pharmaceutical and biopharmaceutical companies, regulators and those from academic centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For questions about the meeting, please contact:

Kent Simmons
Senior Conference Director
Cambridge Healthtech Institute
Phone: 207-869-9199

For partnering & sponsorship information, please contact:

Companies A-K
Jason Gerardi
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5452
Fax: 781-972-5470

Companies L-Z
Carol Dinerstein
Director, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5471
Fax: 781-972-5470